H.I.G. completes BioVectra buyout

H.I.G. Capital has closed its previously announced acquisition of BioVectra Inc, a contract development and manufacturing organization of active pharmaceutical ingredients and intermediates. No financial terms were disclosed.

DealsNorth AmericaUSHealthcareBriefs